Drug Marketing Archives

Apr23
FDA Warns Pfizer Over Online Viagra Ads
Everyone's seen the Viagra ads set to the tune of "Viva Las Vegas" by Elvis Presley well the U.S. Food and Drug Administration recently warned Pfizer over its online "Viva Viagra" ads because the ad failed to detail the drug's...
Feb 7
Pfizer's Lipitor Ad Gets U.S. Congress's Attention
The U.S. Congress House committee on energy and commerce in taking a closer look at Pfizer's advertisement for Lipitor that was endorsed by Robert Jarvik.Jarvik, inventor of the artificial heart is featured in the ad wearing a white doctor's coat... Continue Reading
Merck Agrees to Pay $671M to Settle Rebate Accusations
U.S prosecutors and Merck & Co. (NYSE:MRK) officials announced that a settlement has been reached over claims that the pharmaceutical company overcharged Medicaid and had improperly marketed medications to doctors.Merck agreed to settle a Philadelphia case concerning improper Medicaid rebate... Continue Reading
Jan22
Merck, Schering On The Defensive
In response to the dismal results of a study released last week Schering-Plough and Merck Co.are publicly defending their cholestorol treatments, Vytorin and Zetia. In an attempt to stem the damage the negative publicity surrounding the results of a failed study, both... Continue Reading
Nov28
GlaxoSmithKline Gets Warned by FDA
The U.S Food and Drug Administration has warned GlaxoSmithKline plc (NYSE:GSK) over misleading letters the company sent to health professionals promoting its breast cancer drug, Tykerb.The FDA found that the letters sent out by Glaxo "are misleading in that they omit... Continue Reading
Nov27
Report From Eularis Examines Pharma Sales Force Effectiveness
Previous reports have shown that sales forces represent the largest pharmaceutical company expense however; recent reports show that there is a decline in the return on investment in recent years.Due to the fact that this is such a critical issue,... Continue Reading
 


IAG Research's List of Most Memorable TV Commercial 2006-2007
National Pharma Free Week Oct 22
Lilly Gets Hand Slap from FDA over Cymbalta Advertising
Once Daily Advagraf® Launched Across Europe
Drug Theft and Counterfeiting Costs Industry $71 Billion Annually
Bristol-Myers Squibb Settles with Federal Government for $515M
Pharma to be Held Accountable for Giveaways?
Lipitor Better than Zocor says Pfizer Study
What is the "Walmart Effect"?
Online Pharma Marketing
USFDA Gave Final Approval to Lupin’s Cefdinir for Oral Suspension 250 mg/5 mL
U.S. Senate Blocked Efforts to Allow Prescription Drug Importation
Bayer Healthcare and Intendis Collaborates to Promote Yaz® for Moderate Acne Treatment
Victory Pharma, Inc. Completed Acquisition of Naprelan®
Eli Lilly’s Canine Separation Anxiety Drug Reconcile™, Approved for Marketing by the USFDA
U.S. Marketing Rights to ALZA Corp.’s OROS® Hydromorphone, Bagged by Neuromed Pharmaceuticals
The USFDA, Podcasting and Drug Safety Information
Vote to Allow Medicare to Negotiate Lower Drug Prices, Blocked by Senate Minority
Where the Big Bucks in Pharma Goes: Part 5 Video
Bill Clinton on Pharmaceutical Companies
The Big Bucks in Pharma is Spent on Advertising
USFDA Granted Final Approval to Mylan’s Glipizide and Metformin Hydrochloride Tablets
New Dose of RISPERDAL® CONSTA® for Treatment of Schizophrenia, Approved by the USFDA
Lupin’s Novel Formulation of Suprax® Suspension, Approved by the USFDA
GRIFULVIN V®/Griseofulvin Oral Suspension: Voluntarily Recalled by Ortho-McNeil Pharmaceutical, Inc.
USFDA New Drug Application (NDA) of Anesthetic Reversal Agent NV-101, Submitted by Novalar
Schering-Plough’s PEGINTRON™ Approved in China for Treatment of Chronic Hepatitis B
USFDA Approved Abbott’s New Coated Niaspan®
AVEO and Schering-Plough, Under Worldwide License and Development Agreement for AV-299
CSL Biotherapies Submitted BLA to the USFDA for Introduction of Flu Vaccine into U.S. Market
Boston Scientific’s TAXUS® Express2™ Stent System, Approved in Japan
Abbott Submitted E.U. and U.S. Regulatory Application for HUMIRA® (Adalimumab) as Psoriasis Treatment
U.S. Marketing Rights to Novel Menopause Drug EvaMist™, Acquired by KV Pharmaceutical Company
Novartis Heeds FDA Request to Suspend US Marketing and Sales of Zelnorm®
China Biopharma Signed Distribution Agreement with Takeda Pharmaceutical
MINRAD’s Sevoflurane, Approved in Japan
NOXAFIL® (Posaconazole) is Recommended by New Cancer Practice Guidelines for Antifungal Prophylaxis in Certain High-Risk Patients
Micromet and TRACON Pharmaceuticals Entered Exclusive Worldwide License Agreement for the Development and Commercialization of Humanized Antibody against Cancer
Abeille Pharma’s Transdermal Patch for Emesis, Licensed to SymBio Pharma for Commercialization in Japan and Pacific Rim Countries
GSK Expands Patient Assistance Program to Include Breast Cancer Drug TYKERB®

Drug Marketing Archives

Advertise

Watch the Digital Health Revolution


sponsored ads



Incredible Hall of Acclaim.

subscribe


Prefer Email?
Subscribe below-

Enter your Email:


Powered by FeedBlitz What's this?

Current News

Support This Blog

top blogs

business social media

Use these fast growing business social media sites to promote your business, feature your products, spotlight your business leaders, create links, and drive traffic back to your company site, all for free!

BIZZlogos - Add your logo - free link to your site
BIZZphotos - Add photos of your products and people
BIZZprofiles - Submit your profile and build your online visibility
BIZZspotlight - Spotlight your business with free links
BIZZvideos - Videos about businesses, products and business people.
BIZZbites - "Digg" for Business - Submit your articles and posts

know more media network

View Network Map

Network Feed List (OPML)

Know More Media Network
Feed


we support unitus

PRWeb

Influencer



PharmaGazette is a member of the Know More Media network of business related blogs.

Here are some current headlines from some of our business publications:

ProductivityGoal

CallCenterScript

AdHurl

TheBizofKnowledge

LandingTheDeal

CustomersAreAlways

HealthCareVox

WebMetricsGuru

TheInsurancePolicy

MarketingBlurb